This Executive Order demonstrates a significant consolidation of power within the executive branch, utilizing national security concerns to justify broad intervention in international trade and domestic pharmaceutical pricing. It raises serious concerns about democratic erosion through the bypassing of legislative processes and the potential for arbitrary enforcement. While executive orders are not unprecedented, the scope and aggressive tone of this order, coupled with the potential for undermining the rule of law, are highly concerning and indicative of authoritarian patterns.